DE69625354D1 - Relaxinartiger faktor und damit zusammenhängende verfahren und verwendungen - Google Patents

Relaxinartiger faktor und damit zusammenhängende verfahren und verwendungen

Info

Publication number
DE69625354D1
DE69625354D1 DE69625354T DE69625354T DE69625354D1 DE 69625354 D1 DE69625354 D1 DE 69625354D1 DE 69625354 T DE69625354 T DE 69625354T DE 69625354 T DE69625354 T DE 69625354T DE 69625354 D1 DE69625354 D1 DE 69625354D1
Authority
DE
Germany
Prior art keywords
relaxin
factor
related methods
analogs
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69625354T
Other languages
English (en)
Other versions
DE69625354T2 (de
Inventor
Christian Schwabe
Elaine Unemori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of South Carolina
Connetics Corp
Connective Therapeutics Inc
Original Assignee
University of South Carolina
Connetics Corp
Connective Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of South Carolina, Connetics Corp, Connective Therapeutics Inc filed Critical University of South Carolina
Publication of DE69625354D1 publication Critical patent/DE69625354D1/de
Application granted granted Critical
Publication of DE69625354T2 publication Critical patent/DE69625354T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/64—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE69625354T 1995-06-07 1996-05-16 Relaxinartiger faktor und damit zusammenhängende verfahren und verwendungen Expired - Lifetime DE69625354T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/484,219 US5911997A (en) 1995-06-07 1995-06-07 Relaxin-like factor and methods and uses thereof
PCT/US1996/007399 WO1996040186A1 (en) 1995-06-07 1996-05-16 Relaxin-like factor and methods and uses thereof

Publications (2)

Publication Number Publication Date
DE69625354D1 true DE69625354D1 (de) 2003-01-23
DE69625354T2 DE69625354T2 (de) 2003-10-30

Family

ID=23923245

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69625354T Expired - Lifetime DE69625354T2 (de) 1995-06-07 1996-05-16 Relaxinartiger faktor und damit zusammenhängende verfahren und verwendungen

Country Status (9)

Country Link
US (2) US5911997A (de)
EP (1) EP0831871B1 (de)
JP (1) JP3830520B2 (de)
AT (1) ATE229340T1 (de)
AU (1) AU709115B2 (de)
CA (1) CA2224080C (de)
DE (1) DE69625354T2 (de)
ES (1) ES2188763T3 (de)
WO (1) WO1996040186A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0845992B1 (de) * 1995-08-15 2002-11-20 Connetics Corporation Verwendung von relaxin zur stimulierung der angiogenese
DE19641378C1 (de) * 1996-09-27 1998-04-02 Ihf Inst Fuer Hormon Und Fortp Diagnosehilfe sowie Verfahren zum Nachweis der Trächtigkeit von Wiederkäuern
GB9717652D0 (en) * 1997-08-20 1997-10-22 Nycomed Imaging As Method
AUPR814401A0 (en) 2001-10-08 2001-11-01 Howard Florey Institute Of Experimental Physiology And Medicine Human 3 relaxin
US20050186526A1 (en) * 2002-11-01 2005-08-25 Bas Medical, Inc. Methods and systems for enabling and stabilizing tooth movement
AU2003903124A0 (en) * 2003-06-20 2003-07-10 Mark Del Borgo Analogues of heteromeric proteins
US7878978B2 (en) * 2004-03-18 2011-02-01 University Of Pittsburgh- Of The Commonwealth System Of Higher Education Use of relaxin to increase arterial compliance
EP1753449A4 (de) * 2004-04-30 2009-09-23 Corthera Inc Verfahren und zusammensetzungen zur steuerung des fötalen wachstums mittels relaxin-modulation
US20060052304A1 (en) * 2004-09-02 2006-03-09 Bas Medical, Inc. Method for remodeling bone and related sutures
WO2007093220A1 (en) * 2006-02-17 2007-08-23 Associazione Foresta Per La Ricerca Nella Riproduzione Umana Use of insulin-like factor 3 for treating osteoporosis and bone disorders
EP2368114A4 (de) * 2008-11-24 2012-06-13 Corthera Inc Vorhersage und vorbeugung von präeklampsie
EP2605789B1 (de) 2010-08-17 2019-06-05 Ambrx, Inc. Modifizierte relaxinpolypeptide und ihre verwendungen
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
CA2842395A1 (en) * 2011-08-04 2013-02-07 Pharis Biotec Gmbh Process for preparing human relaxin-2
US20160152679A1 (en) * 2012-05-24 2016-06-02 Angion Biomedica Corp. Relaxin-like compounds and uses thereof
US9393288B2 (en) 2012-05-29 2016-07-19 The University Of Vermont And State Agricultural College Methods of treating diseases associated with PPARγ
US20160060322A1 (en) * 2012-09-10 2016-03-03 Angion Biomedica Corp. Relaxin-like peptides and uses thereof
CA2924109A1 (en) 2013-09-13 2015-03-19 The California Institute For Biomedical Research Modified therapeutic agents and compositions thereof
KR102455171B1 (ko) 2013-12-18 2022-10-14 더 스크립스 리서치 인스티튜트 변형된 치료제, 스테이플드 펩티드 지질 접합체, 및 이의 조성물
MA41794A (fr) * 2015-03-18 2018-01-23 The California Institute For Biomedical Res Agents thérapeutiques modifiés et compositions associées
DK3387019T3 (da) 2015-12-09 2022-01-10 Scripps Research Inst Relaxin-immunoglobulinfusionsproteiner og anvendelsesfremgangsmåder
MX2019008449A (es) 2017-02-08 2019-09-09 Bristol Myers Squibb Co Polipetidos de relaxina modificada que comprenden un mejorador farmacocinetico y sus usos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3382117D1 (de) * 1982-08-12 1991-02-21 Florey Howard Inst Molekulare klonierung und charakterisierung der das menschliche relaxin kodierenden gen-sequenz.
US4835251A (en) * 1986-06-23 1989-05-30 Genetech, Inc. Method of chain combination
US5166191A (en) * 1991-08-19 1992-11-24 Genentech, Inc. Use of relaxin in cardiovascular therapy
US5478807A (en) * 1991-08-19 1995-12-26 Genentech, Inc. Use of relaxin in the treatment of bradycardia

Also Published As

Publication number Publication date
EP0831871B1 (de) 2002-12-11
US20030158376A1 (en) 2003-08-21
JPH11512072A (ja) 1999-10-19
US5911997A (en) 1999-06-15
WO1996040186A1 (en) 1996-12-19
ATE229340T1 (de) 2002-12-15
CA2224080A1 (en) 1996-12-19
DE69625354T2 (de) 2003-10-30
EP0831871A1 (de) 1998-04-01
EP0831871A4 (de) 1999-03-03
JP3830520B2 (ja) 2006-10-04
AU709115B2 (en) 1999-08-19
CA2224080C (en) 2010-07-27
ES2188763T3 (es) 2003-07-01
US6949506B2 (en) 2005-09-27
AU5869996A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
DE69625354T2 (de) Relaxinartiger faktor und damit zusammenhängende verfahren und verwendungen
UA39099C2 (uk) Циклічні азотовмісні похідні, суміш їх ізомерів або окремі ізомери, або їх солі
DE69315503D1 (de) Aufblaseinrichtung für Gaskissen mit inhibierten, gaserzeugenden Zusammensetzungen
DE69424517D1 (de) Gaserzeugende Zusammensetzungen
DE69716135T2 (de) In 6-position durch thio substituierte paclitaxele
DE69216532T2 (de) Azidfreie gaserzeugende Zusammensetzungen
ES2195970T3 (es) L-ribavirina y usos de la misma.
DE69004692T2 (de) Kohlenwasserstoffzusammensetzungen und Zusätze dafür.
MX9203396A (es) Monohidrato de furoato de mometasona, proceso para producirlo y composiciones farmaceuticas.
MX9202496A (es) Composiciones de revestimiento mezcladas.
BG102259A (en) Compostions with controlled paroxetine release
DK1144472T3 (da) Vandige reaktive spartelmasser (II)
PT717041E (pt) Hidratos de paclitaxel cristalinos
DE69421784T2 (de) Kraftstoffzusammensetzungen, und Zusätze dafür
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
IL109720A (en) N-alkylthio polyamine derivatives and radioprotective compositions containing them
EA199800534A1 (ru) ПРИМЕНЕНИЕ 2-ЭТИЛГЕКСИЛ-α-ЦИАНО-β, β-ДИФЕНИЛАКРИАТА ДЛЯ УЛУЧШЕНИЯ СТАБИЛЬНОСТИ КОСМЕТИЧЕСКИХ КОМПОЗИЦИЙ, СОДЕРЖАЩИХ П-МЕТИЛБЕНЗИЛИДЕНКАМФОРУВ СОЧЕТАНИИ С ДИБЕНЗОИЛМЕТАНОВЫМ ПРОИЗВОДНЫМ
DE68920622D1 (de) Polyketonzusammensetzungen.
MX9602836A (es) MEZCLA QUE CONTIENE UNO O VARIOS ALFA-AMINOACIDOS Y SUS DERIVADOS, O AMBOS, Y UNO O VARIOS CICLOPENTANO- beta-AMINOACIDOS Y SUS DERIVADOS, O AMBOS.
MX9603199A (es) Antagonistas de receptores a endotelina.
ATE305517T1 (de) Neurotrypsin
DK0720597T3 (da) Triarylethylenderivater til terapeutisk anvendelse
DK0457127T3 (da) Spermicidt belægningsmiddel
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
DE68917051T2 (de) Rheologisches Zusatzmittel für Überzugsmassen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition